Steth IO vs ElucidVivo A.3
AI Verdict
Choose Steth IO if…
Choose Steth IO if you need a portable, real-time diagnostic tool for remote patient assessment and monitoring. It excels in telemedicine scenarios where clinicians require immediate auscultation and visualization of heart and lung sounds to enhance diagnostic accuracy from a distance. This tool is ideal for integrating physical exam data into virtual care workflows and continuous remote monitoring programs.
View Steth IO →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if your primary need is advanced, quantitative analysis of arterial plaque composition from CT angiography for cardiovascular risk stratification. This AI-powered system is best suited for cardiologists and radiologists seeking detailed insights into plaque stability and characteristics to optimize treatment decisions for patients with atherosclerosis. It provides objective measurements and visualizations validated against histology, crucial for complex case management.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Steth IO | ElucidVivo A.3 |
|---|---|---|
| Pricing | Customized pricing; subscription-based for steth io spot. | Unknown |
| Deployment | Mobile app, Cloud-based system. | Cloud and on-premise secure deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Steth IOSteth IO (Tool A) offers a smartphone-powered stethoscope with a mobile app, providing real-time visualization, recording, and sharing of heart and lung sounds. Its design for individual practitioners and mobile nature suggests a more intuitive and accessible user experience. ElucidVivo A.3 (Tool B), while powerful, is a specialized medical image analysis system requiring integration with existing imaging workflows, implying a more complex setup and usage for trained personnel.
Clinical Value
ElucidVivo A.3ElucidVivo A.3 (Tool B) provides highly specialized, quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology, and derives fractional flow reserve (FFRct). This offers deeper, more nuanced insights into atherosclerosis and has demonstrated improved predictive accuracy for events like stroke. Steth IO (Tool A) enhances fundamental diagnostic auscultation, but Tool B's impact on complex cardiovascular disease management, backed by histology validation, offers superior clinical value in its specialized domain.
Pricing & Value
Steth IOSteth IO (Tool A) provides transparent pricing details, including customized pricing for clinics and an annual membership for Steth IO Spot at $15/month. This transparency allows potential users to more easily assess the value proposition. ElucidVivo A.3 (Tool B) only states 'contact for pricing,' which makes it difficult to evaluate its value without direct engagement.
Enterprise Readiness
ElucidVivo A.3ElucidVivo A.3 (Tool B) is designed as a software application that integrates with PACS/EMR systems, which is standard for medical imaging software in enterprise healthcare environments. While its HIPAA compliance is implied by FDA clearance and intended use, its integration capabilities are a strong indicator of enterprise readiness. Steth IO (Tool A) explicitly states 'user responsible for compliance' and includes a 'HIPAA warning for email export,' which suggests potential complexities or additional responsibilities for enterprise-level HIPAA adherence.
Innovation
ElucidVivo A.3ElucidVivo A.3 (Tool B) demonstrates greater innovation by providing a unique, FDA-cleared, histology-validated quantitative analysis of arterial plaque composition and stability from CT angiography, including the derivation of FFRct. This offers new types of predictive insights for personalized atherosclerosis management, moving beyond traditional diagnostic assistance. Steth IO (Tool A) is innovative in transforming a smartphone into a digital stethoscope, but Tool B's specialized AI application for advanced plaque characterization represents a more profound technological advancement in its field.
Support & Docs
TieWhile Steth IO (Tool A) provides a user guide and contact information for support, and Elucid Bioimaging (Tool B) has a company website, specific details regarding comprehensive public documentation, structured support channels, or service level agreements are not explicitly outlined for either tool in the provided facts or readily available through general web searches. Therefore, it is difficult to distinguish a clear winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Steth IO | ElucidVivo A.3 |
|---|---|---|
| Product Name | Steth IO | ElucidVivo A.3 |
| Company | STRATOSCIENTIFIC | Elucid Bioimaging |
| Primary Function | Smartphone stethoscope that transforms a mobile device into a diagnostic aid for hearing, visualizing, recording, and sharing heart and lung sounds. | AI-powered medical image analysis system providing quantitative analysis of arterial plaque composition and stability from CT angiography. |
| Core Technology | Smartphone-powered stethoscope hardware and app with digital filters for sound enhancement and ambient noise attenuation. | AI-powered quantitative analysis of arterial plaque from CT images. |
| Key Diagnostic Output | Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram); recorded patient exams. | Quantitative analysis of Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications; 3D visualization of highlighted vessels; fractional flow reserve (FFRct) derivation. |
| Target Specialties | Cardiology, Internal Medicine, Pulmonology | Cardiology, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring Steth IO and ElucidVivo A.3.